Atherosclerosis Forum-1
|
13:30-15:30 207 |
|---|
| 主持 Moderators | 周玉杰 Yujie ZHOU, 马晓峰 Xiaofeng MA, 王毅 Yi WANG, 金红峰 Hongfeng JIN, 裘晟 Cheng QIU, 隋向前 Xiangqian SUI | ||
|
13:30-13:50 |
GLP-1RA与ASCVD GLP-1RA and ASCVD |
李勇 Yong LI | |
|
13:50-14:10 |
CKM时代下的血脂管理策略 Lipid Management Strategy in the CKM Era |
包丽雯 Liwen BAO | |
|
14:10-14:30 |
家族性高胆固醇血症诊疗管理进展与未来展望 Progress and Future Prospects in the Diagnosis, Treatment and Management of Familial Hypercholesterolemia |
陈红 Hong CHEN | |
|
14:30-14:50 |
肥胖和心血管疾病-ESC临床指南解读 Obesity and Cardiovascular Diseases - Interpretation of ESC Clinical Guidelines |
袁祖贻 Zuyi YUAN | |
|
14:50-15:10 |
改善HDL功能可以使心血管获益吗 Can Improving HDL Function Benefit Cardiovascular Health? |
叶平 Ping YE | |
|
15:10-15:30 |
讨论 Discussion |
||
Atherosclerosis Forum-2
|
15:30-17:30 207 |
|---|
| 主持 Moderators | 孔祥清 Xiangqing KONG, 黄恺 Kai HUANG, 黄晶 Jing HUANG, 谢伟 Wei XIE, 童国新 Guoxin TONG, 李海如 Hairu LI | ||
|
15:30-15:50 |
女性特殊时期（妊娠、哺乳、围绝经期）血脂水平评估和管理 Evaluation and Management of Blood Lipid Levels in Women During Special Periods (Pregnancy, Lactation, Perimenopause) |
张大庆 Daqing ZHANG | |
|
15:50-16:10 |
神经酰胺，控制残余风险的靶标？ Ceramide: A Target for Controlling Residual Risk? |
郑金刚 Jingang ZHENG | |
|
16:10-16:30 |
中国基层血脂异常管理2024指南解读 Interpretation of the 2024 Guidelines for the Management of Dyslipidemia in Primary Care in China |
王增武 Zengwu WANG | |
|
16:30-16:50 |
冠心病抗炎治疗 Anti-Inflammatory Treatment of Coronary Heart Disease |
刘震宇 Zhenyu LIU | |
|
16:50-17:10 |
ACS血脂异常管理指南更新的思考 Reflections on the Update of Guidelines for the Management of Dyslipidemia in ACS |
杨文艺 Wenyi YANG | |
|
17:10-17:30 |
从CKM到SMD From CKM to SMD |
黄恺 Kai HUANG | |